Cosmetic Science Laboratories LLC was cited for significant Current Good Manufacturing Practice (CGMP) violations at its drug manufacturing facility in Torrance, California during a September 2022 inspection of sunscreen and other drug products. The company failed to maintain proper manufacturing methods, facilities, and controls for finished pharmaceuticals, rendering its drug products adulterated under federal law. Additionally, the firm had not submitted required FDA registration updates or drug listing information for multiple products, including a product identified only as SPF-30. The company's October 2022 response to the inspection findings was determined to be inadequate, lacking sufficient detail and evidence of corrective actions.